Watch for the First Oral GLP-1 Agonist, Rybelsus, During Transitions of Care

Semaglutide (Rybelsus, reh-BEL-sus) will be the first ORAL GLP-1 agonist for type 2 diabetes....

Get unlimited access through an Enterprise license

Hospital Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Not sold to individuals